CXCL9 and Sepsis: However, sepsis prevented efficient recruitment of CTV+ cells upon TRM peptide activation that was restored after exogenous CXCL9/10 administration (Fig 8H and 8I) suggesting a potential way to correct sepsis-induced impairments in effector cell recruitment to the site of localized infection/inflammation.